Frontlight ResearchEarly access
Taking peopleNo phase
Acute Treatment and Long-term Assessment of Adult Infectious Meningitis
Key facts
- Who runs it
- Hospital Israelita Albert Einstein
- Where
- Brazil6 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 624 people, planned
- Started
- 30 Mar 2026
- Expected to end
- Feb 2027
- Type of study
- Observational
- Record updated
- 5 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Both sexes, aged ≥ 18 years, meeting one or more of the criteria (A, B or C) below:
- --> Criterion A: Clinical presentation compatible with a suspected case of meningitis or meningococcal disease:
- Fever ≥ 37.8 °C (axillary) associated with at least two of the following:
- Severe headache
- Vomiting
- Altered level of consciousness (confusion, drowsiness, irritability)
- Photophobia
- Seizure OR Fever associated with one of the classic signs of meningeal irritation (neck stiffness, Kernig or Brudzinski signs) OR Sudden-onset fever with petechial rash or hemorrhagic suffusions; Criterion B: Cerebrospinal fluid with leukocytes ≥ 5 cells/mm³ (corrected for red blood cell count at 1:500); Criterion C: Confirmed etiological diagnosis of meningitis or meningococcal disease with no more than 48 hours between pathogen confirmation and signature of the informed consent form by the participant or legal representative
Who cannot take part
- Use of an intraventricular device prior to study inclusion
- Presence of a neurological condition, other than meningitis, that accounts for the current clinical picture
- Etiological diagnosis of meningitis or meningococcal disease confirmed more than 48 hours earlier
- Clinical, laboratory or radiological evidence of an alternative infectious focus that accounts for the current clinical picture
- Refusal to provide consent for the study
This trial is currently available in Brazil.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Prospective, multicenter, observational clinical registry of adult patients with acute infectious meningitis across approximately 30 public and private hospitals in Brazil. The study will include adults, 18 years old and older, with suspected acute infectious meningitis. Data will be collected during hospitalization and post-discharge to evaluate clinical management, treatment and short and long-term outcomes. The study aims to generate real-world evidence on current practices and outcomes to support improvements in national care protocols.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Adults Meningitis
- Record updated
- 5 November 2026